Guidelines for long-term management of patients with Kawasaki disease. Report from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.
A S Dajani(American Heart Association), William Wilson(Cancer Research UK), Adolf W. Karchmer(Beth Israel Deaconess Medical Center), Patricia Ferrieri, Michael A. Gerber(Gerber Technology (United States)), Michael D. Freed(Harvard University), Stanford T. Shulman, Masato Takahashi(National Hospital Organization Hokkaido Medical Center), F Z Bierman(American Heart Association), Kathryn A. Taubert(Brigham and Women's Hospital)
Cited by 274
Related Papers
Markers of Inflammation and Cardiovascular Disease
|Circulation|2003|6.3k
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
|Clinical Infectious Diseases|2011|4.2k
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
|Circulation|2017|3.7k
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k
Prevention of Infective Endocarditis
|Circulation|2007|2.8k